Marketing-authorisation holder · United States
Apgdi
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MYRBETRIQ25mg | 50mg · Tablet, extended release | Mirabegron | United States | Marketed | 2012 |
| MYRBETRIQ GRANULES8mg/ml · For suspension, extended release | Mirabegron | United States | Marketed | 2021 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.